Cargando…
Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Cancer is one of the leading causes of death worldwide due to high heterogeneity. Although chemotherapy remains the mainstay of cancer therapy, non-selective toxicity and drug resistance of mono-chemotherapy incur broad criticisms. Subsequently, various combination strategies have been developed to...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644565/ https://www.ncbi.nlm.nih.gov/pubmed/36348391 http://dx.doi.org/10.1186/s40164-022-00347-1 |